. Conformational Change Induced by TCR-CD3 Antibodies (A) 31-13.scTCRβ cells were incubated with antibodies against different epitopes of the TCR-CD3 complex: anti-CD3ε (α-CD3, OKT3), anti-TCRβ constant region (α-Cβ, Jovi1) and anti-TCRβ variable region (α-Vβ3, Jovi3). The Nck-pull-down assay and protein detection were done as described (left panel). To control binding, an aliquot of each of the stimulated cells was stained with a PE-labelled anti-IgG antibody (right panel). (B) Jurkat T cells were stimulated with anti-CD3ε (α-CD3, OKT3), anti-TCRβ constant region (α-Cβ, Jovi1) and anti-TCRβ variable region BV8) antibodies. Samples were processed as above. These experiments demonstrated that the amount of conformational change induced by TCR-CD3 antibodies depends on the epitope recognized. (C) SRD10 cells were stimulated with the anti-TCRαβ 3D3, the 3D3 Fab fragment or a combination of the Fab fragment and anti-Ig light chain antibody. As control, cells were also left unstimulated. The Nck-pull-down assay and detection of the proteins by immuno-blotting were done as previously described. To control binding, an aliquot of each of the samples was stained with an anti-IgG antibody coupled to FITC. Fluorescence was measured by flow cytometry. The cell number of the Fabstimulated samples was reduced electronically, in order to prevent overlapping of the graphs. This experiment demonstrated that bivalent, but not monovalent, anti-TCRαβ can induce the conformational change at CD3.
Figure S2. Loss of MHCp Binding Results in Loss of the Conformational Change
(A) A T cell clone from T1 transgenic mice was incubated with 5 nM K d -pepABA tetramer or 5 µg/ml anti-CD3. Cells were then UV irradiated to fix the MHCp to the TCR (lanes 4-6) or left untreated (lanes 1-3). Upon lysis, the Nck-pull-down assay was performed and TCR-CD3 detected by anti-ζ, anti-CD3ε and the TCRαβ-bound MHCp tetramer by anti-β2-microglobulin immuno-blotting. As control, an aliquot of each lysate was separated by SDS-PAGE and equal loading confirmed by anti-ζ Western Blotting. In addition, an anti-CD3 immuno-precipitation was performed and presence of MHC detected with an anti-β2-microglobulin (lower panel). (C) The sequence of the divalent peptides that contain two NIP-conjugated lysine are shown. The one letter code for amino acids is used. The first number in the name of the peptide indicates the number of NIP-conjugated lysines contained in the sequence and the second number indicates the number of amino acids between two adjacent NIP-conjugated lysines. A peptide with a distance equivalent to 200 amino acids between two NIP-conjugated lysines (NIP2.200-peptide) was synthesized by repeating 7 times a unit of 5 amino acids coupled to a glycol spacer (Ttds), this peptide was then coupled to a NIP-conjugated lysine using the same glycol spacer and subsequently covalently dimerized with the BM(PEO) 4 cross-linker (Pierce). (C) 31-13.scTCRβ cells were incubated with an excess of the indicated NIP-peptides, NIP15-BSA or left untreated for 30 minutes at 4°C in presence of NaN 3 . Concentrations of the NIP-coupled stimuli were chosen, so that the number of NIP molecules was constant (2.8x10 6 NIPs/ml). After a washing step, cells were incubated with the anti- sc Ac146 for 15 minutes at 4°C in presence of NaN 3 . Cells were washed, and the anti-sc antibody was detected by incubation with an anti-mouse IgG-PE. Fluorescence was measured by flow cytometry and the mean fluorescence intensity is displayed. The NIP molecule competes with the anti-sc for binding to the scTCR (Reth et al., 1979) . Therefore, the degree of reduction of anti-sc binding directly reflected the number of scTCRs that were bound to the NIP-coupled peptides. (D) The concentration of the indicated NIP-coupled stimuli to optimally stimulate 31-13.scTCRβ cells (2.8x10 4 NIPs/ml), was determined empirically using stimulationinduced tyrosine-phosphorylation in lysates as read-out (data not shown). This concentration was used in all stimulations of the present publication (except Figure  S4A) . Equal binding of the NIP-stimuli to 31-13.scTCRβ cells at this stimulating concentration was assayed as described in (A). In conclusion, when concentrations of the peptides were chosen, so that the number of NIP molecules per stimulation was constant, then the same number of TCR-CD3s was bound to NIP, independent of the peptide used. Figure S4 . Induction of the Conformational Change Is Independent of Intercellular Clustering of TCR-CD3s (A) 31-13.scTCRβ cells were incubated with the indicated NIP-peptides (2.8x10 4 NIPs/ml) or left untreated (left columns). As control, cell clusters were formed by incubation of 31-13.scTCRβ cells which were stained with biotin-coupled anti-TCR, with B cells which were stained with biotin-coupled anti-IgM, in the presence of streptavidin. After fixation of the cells with 1% paraformaldehyde in PBS, cells were counted in a light microscope and formation of cell clusters was quantified. 500 cells were counted in each sample. The mean of three independent experiments and the standard deviation are shown. (B) 10 7 31-13.scTCRβ cells were stimulated in the indicated volumes at a constant stimuli concentration for 5 minutes at 37°C. The concentration of the stimuli was 2.8x10 4 NIPs/ml for the NIP-peptides and 5 µg/ml for the anti-CD3 (OKT3). To keep the cellular concentration constant over the entire stimulation time, cells were lysed omitting the standard centrifugation step. Consequently, the Nck pulldown assay and detection of the TCR-CD3 were performed as before.
These two experiments demonstrate that the conformational change is not induced by clustering two TCR-CD3s that are expressed on two different cells. Therefore, TCR clustering occurs within the same membrane. Figure S5 . The Exposure of the PRS Correlates with T Cell Activation (A) 31-13.scTCRβ cells were loaded with Indo-1 and stimulated with NIP-coupled peptides that contain two NIP molecules separated by different distances. Importantly, all of them are bivalent and thus can simultaneously bind two TCR-CD3, but induce the conformational change with varying degrees. Equal molarities of these NIPcoupled reagents were used. To measure Ca 2+ responses the indo-1 ratio was integrated over 10 minutes and measured by flow cytometry. The stimuli were added after 1 minute of recording (arrow). (B) 31-13.scTCRβ cells were stimulated with equal molarities of the indicated NIPcoupled reagents for 24 hours or left untreated. After staining with an anti-CD69, cells were analyzed by flow cytometry and the percent of CD69 positive cells displayed. The mean of triplicates and the standard deviation are indicated. Thus, the capacity to induce the conformational change correlates with the capacity of the NIP-modified peptides to stimulate Ca 2+ -influx and to upregulate the activation marker CD69. (C) 31-13.scTCRβ cells were loaded with Indo-1 and stimulated with 5 µg/ml of the anti-CD3ε Fab fragment (OKT3), 1 µg/ml of an anti-kappa light chain or both stimuli simultaneously. Indo-1 ratio was integrated over 10 minutes and the stimuli were added after 1 minute (arrow). Stimulation with anti-CD3ε Fab fragments, which induce the conformational change, did not lead to a Ca 2+ -influx. When the anti-CD3ε Fab fragments were multimerized by anti-kappa, a Ca 2+ -influx was detected. This indicates that the anti-CD3ε Fab fragments had bound to the T cells and that the conformational change is not sufficient to induce Ca 2+ -influx. (D) 31-13.scTCRβ cells loaded with Indo-1 were stimulated with the indicated stimulus as described in (C). Supplementation of the monovalent NIP1-peptide, which itself does not induce the conformational change, with anti-CD3ε Fab fragments, which do induce the conformational change, did not enhance the capability of the NIP1-peptide to give a Ca 2+ response. Together with the data presented in Figure 6A , this finding indicates that multivalent binding to the TCR-CD3 and the ability to induce the conformational change are sufficient for the NIP-peptides to trigger the TCR-CD3. MHCp monomers and anti-TCRαβ Fab fragments cannot induce the conformational change at CD3ε. Similarly, monomeric NIP binding to scTCRβ does not induce the conformational change (left and center). In those cases, the structure of the TCRαβ heterodimer is not changed at its constants regions which communicate with the CD3 subunits. Thus, CD3ε remains unchanged. On the other hand, Fab fragments of the CD3ε antibodies UCHT1 and OKT3 do induce the conformational change (right). Both Fab fragments bind to a similar epitope that might be partially hidden within the TCR-CD3 complex (Kjer-Nielsen et al., PNAS 101, p7675, 2004 and Arnett et al., PNAS 101, p16268, 2004) . The binding of the anti-CD3ε Fab fragments could displace CD3 from its original position, resulting in the conformational change. As multivalent ligands, MHCp, anti-TCRαβ, NIP and anti-CD3 induce the conformational change.
